22157.jpg
The World Market for Shock Wave Therapy Devices, 2024-2032: Discover the Leading and Fastest-Growing Regional Markets
January 10, 2025 06:07 ET | Research and Markets
Dublin, Jan. 10, 2025 (GLOBE NEWSWIRE) -- The "Shock Wave Therapy Device Market Forecast 2024-2032" report has been added to ResearchAndMarkets.com's offering.The global shock wave therapy devices...
bybit.jpg
C4 Launches KOL Incubation School to Empower the Next Generation of Crypto Content Creators
January 10, 2025 06:05 ET | Bybit Fintech FZE
DUBAI, United Arab Emirates, Jan. 10, 2025 (GLOBE NEWSWIRE) -- The Crypto Content Creator Campus (C4), announces the launch of its C4 KOL Incubation School, a premier program designed to help...
logo_centered_440x386.png
PacBio and Intus Bio Collaborate for Launch of GutID, First At-Home Microbiome Test Powered by HiFi Sequencing
January 10, 2025 06:05 ET | PacBio
MENLO PARK, Calif., Jan. 10, 2025 (GLOBE NEWSWIRE) -- PacBio (NASDAQ: PACB), developer of the world’s most advanced sequencing technologies, and Intus Bio, a leader in microbiome research and...
mersana_logo.png
Mersana Therapeutics Announces Additional FDA Fast Track Designation Granted to Emiltatug Ledadotin (XMT-1660)
January 10, 2025 06:02 ET | Mersana Therapeutics, Inc.
CAMBRIDGE, Mass., Jan. 10, 2025 (GLOBE NEWSWIRE) -- Mersana Therapeutics, Inc. (NASDAQ: MRSN), a clinical-stage biopharmaceutical company focused on discovering and developing a pipeline of...
22157.jpg
Japan Hydraulics Market Research 2020-2030 with 2023 as the Base Year - Revenue, Outlook, Trends, Companies, & Forecasts
January 10, 2025 06:01 ET | Research and Markets
Dublin, Jan. 10, 2025 (GLOBE NEWSWIRE) -- The "Japan Hydraulics Market | Revenue, Outlook, Trends, Companies, Industry, Size, Share, Growth, Analysis, Value & Forecast: Market Forecast By...
mersana_logo.png
Mersana Therapeutics Announces Positive Initial Clinical Data from Phase 1 Clinical Trial of Emiltatug Ledadotin (XMT-1660); Initiation of Expansion in Triple Negative Breast Cancer
January 10, 2025 06:00 ET | Mersana Therapeutics, Inc.
- Emiltatug ledadotin observed to be generally well tolerated with differentiated safety and tolerability profile- Promising clinical activity observed in patients with triple-negative breast cancer...
EXEL Industries: Tot
EXEL Industries: Total number of voting rights and shares at 11.30.2024
January 10, 2025 06:00 ET | EXEL INDUSTRIES
EXEL IndustriesA French Société Anonyme with a share capital of €16,969,750Registered office: 54, rue Marcel Paul - 51206 Epernay Cedex - FranceReims Companies Register (RCS): No. 095 550 356 ...
Biodesix_full color_logo.jpg
Biodesix Announces Preliminary Fourth Quarter and Full-Year 2024 Results (Unaudited)
January 10, 2025 06:00 ET | Biodesix, Inc.
LOUISVILLE, Colo., Jan. 10, 2025 (GLOBE NEWSWIRE) -- Biodesix, Inc. (Nasdaq: BDSX), a leading diagnostic solutions company, today announced its preliminary financial results for the fourth quarter...
EBI Logo.png
Everything Blockchain Inc. Resolves Toxic Convertible Notes, Strengthening Financial Position
January 10, 2025 06:00 ET | Everything Blockchain, Inc.
Jacksonville , Jan. 10, 2025 (GLOBE NEWSWIRE) -- Everything Blockchain Inc. (OTCMKTS: EBZT), a company bridging traditional markets and emerging technologies through strategic investments in AI and...
Primary AH Promotional Logo Full Color.png
Armada Hoffler Announces Morningstar Upgrades Outlook to Stable and Confirms BBB Credit Rating
January 10, 2025 06:00 ET | Armada Hoffler Properties, Inc.
VIRGINIA BEACH, Va., Jan. 10, 2025 (GLOBE NEWSWIRE) -- Armada Hoffler (NYSE: AHH) announced that Morningstar has upgraded its outlook to stable and confirmed its BBB credit rating. “We are...